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Previous studies have shown that the infusion of glucose, fructose and galactose 
resulted in significant increases in intestinal glucose uptake (IGU) and the role of 
nitric oxide in these responses was not known. The present study was designed to 
investigate the role of nitric oxide in the observed increases in IGU. Experiments were 
carried out on thirty-five (35) fasted male anaesthetized Nigerian local dogs divided 
into seven groups (5 dogs per group). Group I dogs served as control and received 
normal saline, groups II-IV dogs were infused with glucose (1.1 mg/kg/min), fructose 
(1.1 mg/kg/min) or galactose (1.1mg/kg/min) while groups V-VII were pretreated 
with L-Nitro-Arginine-Methyl-Esther (L-NAME) (35 mg/kg) after which they were 
infused with glucose (1.1 mg/kg/min), fructose (1.1 mg/kg/min) or galactose 
(1.1mg/kg/min). Through a midline laparatomy, the upper jejunum was cannulated for 
blood flow measurement and blood samples were obtained for measurement of 
glucose content of the arterial blood and venous blood from the upper jejunal 
segment. Glucose uptake was calculated as the product of jejunal blood flow and the 
difference between arterial and venous glucose levels (A-V glucose). Blood pressure 
was recorded continuously. The results showed that pretreatment of the animal with 
L-NAME, caused significant reductions in jejunal blood flow with complete abolition 
of glucose-, fructose- and galactose-induced increases in IGU. The results suggest that 
only glucose-induced IGU was nitric oxide-dependent through the induced hyperemia 





In a recent study, Salman et al;( 2014a), reported that 
intravenous infusion of glucose, fructose or galactose in 
dogs produced significant increases in blood glucose 
and intestinal glucose uptake. This report is similar to 
earlier observations in dogs ( Alada and Oyebola, 1996, 
Alada et al;2005) and rabbits (Oyebola et al; 2009, 
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2011) whereby hyperglycemia  induced by  adrenaline, 
nicotine and glucagon caused significant increases in 
intestinal glucose uptake. It was therefore concluded 
that the gastro-intestinal tract will increase its glucose 
uptake in response to hyperglycemia irrespective of its 
cause. Hence, the gastrointestinal tract plays a 
modulatory role in glucose homeostasis 
The mechanism(s) by which the hyperglycemia 
induced by the hexoses causes a rise in the amount of 
glucose taken up by the intestine is not fully elucidated. 
One of the important regulatory signalling molecules 
produced by the endothelium is nitric oxide (NO), 
which is synthesized from L-arginine by the action of 
three isozymes of Nitric Oxide synthase (NOS) 
(Moncade and Higgs, 1993). Nitric oxide is a well 
known mediator of glucose transport in skeletal muscle 
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during the resting and postexercise state (Balon and 
Nadler, 1997). Nitric oxide-stimulated glucose 
transport is associated with an activation of the α1 
catalytic subunit of AMPK (Higaki et al; 2001). Studies 
by Bian et al; (2001)  showed that different isoforms of 
NOS are expressed in the gastro-intestinal tract. 
Although, the complete physiological function of NO 
in the gastro-intestinal tract is not known, a study by 
Kibourn and Griffith (1992) showed increased 
intestinal permeability in response to high NO 
concentration.  A study by Powell et al; (2004) has also 
shown that presence of high blood glucose 
concentration in human upregulates nitric oxide 
synthase gene-expression in intestinal epithelial cells. 
There is a compelling data from animal studies 
(Alemany et al; 1997, Matheson et al; 1997) showing 
that nitric oxide is involved in the regulation of 
splanchnic blood flow. 
The aim of this study therefore is to assess the role of  
nitric oxide in the observed increases in intestinal 
glucose uptake following hyperglycemia induced by 
glucose, fructose or galactose. 
 
MATERIALS AND METHODS  
Experiments were carried out on male, adult mongrel 
dogs weighing 10 – 15 Kg. Each animal was fasted for 
18 – 24h before the start of an experiment. Anaesthesia 
was induced by i.v. Sodium pentobarbitone, 30mg/kg. 
Light anaesthesia was maintained with supplementary 
doses of i.v. sodim pentobarbitone as necessary. The 
trachea was intubated using a Y-piece cannula and the 
animal was allowed to breathe room air (temp 25 C) 
spontaneously. Cannulae were placed in the right 
femoral veine and right femoral artery. The later was 
advanced to the level of the superior mesenteric artery. 
Through a midline laparatomy, the jejunum was 
identified and a vein draining  the proximal segmenrt of 
the jejunum was cannulated using a 1.8 mm (i.d) 
polyethylene tubing (P.E 260). The jejunal vein cannula 
was moved into an extra-corporeal position and a non-
crushing clamp was applied to its free end. Sodium 
heparin, 300 units per kg was administered i.v. to 
prevent blood clotting . The abdomen was closed in 
two layers with interrupted sutures. 
 
Experimental procedure 
Following surgery, a period of 60 min was allowed for 
stabilization of all animals. After stabilization, basal 
measurements of jejenual venous flow, arterial and 
venous glucose levels were made at 5 min interval over 
15 min. The mean was taken as the control. Jejunal 
blood flow was determined by timed collection of 
blood as previously described (Alada et al; 2005). 
Blood pressure was continuously monitored through 
the right femoral artery connected to physiographic two 
channel recorder (Gemini Model 7070, Ugo Basil, 
Italy).  
Arterial and venous blood samples for glucose 
estimation were obtained from the femoral artery and 
jejunal venous cannulae, respectfully. After the basal 
measurements, a 20 min infusion of glucose (1.1 
mg/kg/min), fructose (1.1 mg/kg/min) or galactose  (1.1 
mg/kg/min) intravenously.  Another group was  
pretreated with L-Nitro-Argenine-Methyl-Ester (L-
NAME, Sigma, USA) 35 mg/kg followed by infusion 
of glucose (1.1 mg/kg/min), fructose (1.1 mg/kg/min) 
or galactose (1.1 mg/kg/min). Five dogs were used for 
each dose of all the sugars studied. Infusion was carried 
out using an infusion pump (Palmer, England). 
Measurement of blood flow and blood sample 
collection were carried out at 0 min, 5 min, 10 min, 15 
min, 20 min, 25 min, 30 min, 45 min, 60 min, 75 min 
and 90 min during and post infusion period. 
Another group of five dogs were studied for the effects 
of normal saline (0.2 ml/kg/min) on jejunal blood flow, 
arterial and venous glucose levels as in other groups. 
This served as the control. Blood glucose was 
determined by modified glucose oxidase method 
(Trinder, 1969). Intestinal glucose uptake was 
calculated as the product of arterio-venous glucose 
difference (A – V) and jejunal blood flow per minute, 
intestinal vascular resistance was also calculated as the 
blood pressure divided by the intestinal blood flow. 
 
 Statistical analysis 
All values given are the means ± SEM of the variable 
measured. Significance was assessed by the Student t-
test for two  Means of independent variables. P values 
of 0.05 or less were taken as statisticall significant. 
 
RESULTS 
Effects of Glucose 
The effects of glucose infusion on arterial and venous 
blood glucose levels, arterio-venous glucose difference, 
jejunal blood flow and intestinal glucose uptake before 
and after pretreatment of the animal with L-NAME are 
shown in table 1 and fig 1. Infusion of glucose 
produced significant increases in arterial and venous 
blood glucose levels. There was also a corresponding 
increase in arterio-venous glucose difference in 
response to infusion of glucose. Pretreating the animal 
with L-NAME caused significant decrease in both 
arterial and venous blood glucose levels. However, 
there was no change in the basal blood glucose before 
and after pretreatment with L-NAME (table 1). 
Infusion of glucose produced a slight but significant 
increase in jejunal blood flow which lasted for about 
twenty minutes (Fig. 1b). This increase in jejunal blood 
flow was completely abolished following pretreatment 
of the dog with L-NAME and the vascular resistance  
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Table 1: Effects of intravenous infusion of glucose on arterial and venous glucose Concentrations (mg/dl) before 
and after pretreatment with L-Nitro-Arginine-Methyl-Ester 
 
*P<0.05, **P<0.01;  ***P<0.001  vs basal;  #p<0.05 vs Glu 
 
 
Table 2: Effects of intravenous infusion of fructose (Fru) (1.1 mg/kg/min) on arterial and venous glucose 
Concentrations (mg/dl) before and after pre-treatment with L-Nitro-Arginine-Methyl-Esther (L-NAME) (35 
mg/kg). 
 
*p<0.05, **p<0.01 vs basal; #p<0.05 vs Fru
 
increased by about four fold (table 4). Glucose infusion 
produced a highly significant increase in intestinal 
glucose uptake. This increase in intestinal glucose 
uptake could be as high as 700%. When the animal was 
pretreated with a NOS inhibitor, L-NAME, the rise in 
intestinal glucose uptake was completely abolished 
(Fig. 1c). 
 
Effects of Fructose. 
The effects of frucose on arterial and venous blood 
glucose, arterio-venous glucose difference, jejunal 
blood flow and intestinal glucose uptake are shown in 
table 2 and Fig. 2. Infusion of fructose produced slight 
but significant increases in arterial and venous glucose 
levels which lasted for about twenty minutes. There 
were also significant increases in arterio-venous 
glucose levels. However, pretreatment of the animal 
with L-NAME had no effect on the blood glucose 
response to fructose infusion. Though, fructose had no 
effect on the jejunal blood flow, pretreating the animal 
with L-NAME significantly decreased the blood flow  
throughout the period of the experiment (Fig 2a).  The 
significant increase of about 600% in intestinal glucose 
uptake  caused by fructose infusion was also 
completely abolished when the animal was pretreated 
with L-NAME before fructose infusion (Fig 2c). 
 
Effects of Galactose 
The effects of infusion of galactose on arterial and 
venous blood glucose levels, arterio-venous glucose 
difference, jejunal blood flow and intestinal glucose 
uptake are  
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Table 3: Effects of intravenous infusion of galactose (Gal) (1.1 mg/kg/min) on arterial and venous glucose 
Concentrations (mg/dl) before and after pre-treatment with L-Nitro-Arginine-Methyl-Esther (L-NAME) (35 
mg/kg). 
 
*P<0.05 compared to basal 
 
 
Fig. 1: Effects of intravenous infusion of glucose on blood flow 
(a), (A-V) glucose (b) and glucose uptake (c) in untreated 
( ) and dogs pretreated with L-NAME ( ) 
 
shown in table 3 and figure 3. Galactose also caused 
slight but significant increases in blood glucose levels. 
Arterio-venous blood glucose difference also increased  
 
 
Fig. 2: Effects of intravenous infusion of fructose on blood 
flow (a), (A-V) glucose and glucose uptake in untreated 
( )  and in dogs treated with L-NAME ( ) 
 
significantly for about twenty minutes during infusion 
of galactose. Pretreatment of the animal with L-NAME 
had no effect on the blood glucose levels and the  
Nitric oxide and intestinal glucose uptake 
11                                                             J. Afr. Ass. Physiol. Sci. 4 (1): July, 2016   Salman and Alada
                              
 
  
Table 4: Vascular changes in response to Glucose, Fructose and Galactose before and after L-NAME treatment. 
Treatment ABP (mmHg) IBF (ml/min) Vascular Resistance (RU) 
Glucose 88.44 ± 1.24 14.4 ± 0.93 6.14 ± 0.49 
L-NAME + Glucose 95.67 ± 1.14 3.5 ± 0.25 27.33 ± 1.67 
Fructose 85.65 ± 0.67 10.8 ± 0.37 7.95 ± 0.91 
L-NAME + Fructose 98.83 ± 1.45 3.4 ± 0.18 29.06 ± 3.13 
Galactose 82.10 ± 1.33 9.75 ± 0.48 8.42 ± 0.66 
L-NAME + Galactose 95.81 ± 0.82 3.23 ± 0.22 29.67 ± 3.83 
 
arterio-venous glucose levels. Galactose had no effect 
on jejunal blood flow, but following pretreatment of the 
animal with the NOS inhibitor, there were significant 
reductions in the jejunal blood flow which was 
sustained during the infusion and post infusion period 
(Fig 3a). Pretreatment of the animal with a NOS 
inhibitor significantly reduced the galactose – induced 
increase in intestinal glucose uptake from 150 mg/min 
to about 50 mg/min.  
 
 
Fig. 3: Effects of intravenous infusion of galactose on blood 
flow (a), (A-V) glucose (b) and glucose uptake (c) in 
untreated ( ) and in dogs pre-treated with L-NAME 
( ). 
 
Effect of normal saline 
Normal saline had no effect on the arterial and venous 
blood glucose levels and arterio-venous glucose 
diference. It also had no effect on the jejunal blood 
flow and intestinal glucose uptake. The resting jejunal 
blood flow was 10.60 ± 0.75 ml/min and the resting 
intestinal glucose uptake was 36.80 ± 8.26 mg/min. 
 
DISCUSSION 
The observed increases in intestinal glucose uptake in 
response to glucose, fructose or galactose in this study 
are consistent with our earlier reports (Salman et al; 
2014) in similar dog experiments. Salman et al; (2014) 
had earlier concluded that the increased intestinal 
glucose uptake was a metabolic response to the 
hyperglycemia induced by glucose, fructose or 
galactose. A major observation in this study is the 
significant reduction or complete abolition of the 
induced increases in intestinal glucose uptake by the 
three sugars following pretreatment of the animal with 
NOS inhibitor, L-NAME. Since L-NAME had no effect 
on blood glucose levels and arterio-venous glucose 
difference, it would be difficult therefore, to suggest 
that nitric oxide is involved in intestinal glucose 
extraction. A plausible explanation for the effect of L-
NAME on the intestinal glucose uptake in this study is 
its effect on blood flow and other vascular parameters 
as seen on table 4. For instance, L-NAME produced a 
slight rise in blood pressure but a tremendous increase 
in vascular resistance which significantly reduced 
intestinal blood flow in all the experiments bringing 
about such a decrease in   intestinal glucose uptake.  
 
There was only a slight but significant increase in 
intestinal blood flow in response to infusion of glucose. 
Interestingly, the other two sugars; fructose and 
galactose did not produce such hyperemia. This 
observed glucose-induced hyperemia had earlier been 
reported in dogs (Alada and Oyebola, 1996, Pencek et 
al; 2004) and is most probably due to secretion of 
insulin which has been reported to possess vasodilatory 
properties (Scherrer and Sartori, 1997). In other words, 
glucose infusion causes hyperinsulinemia which could 
be responsible for the increase in blood flow. The 
involvement of nitric oxide in insulin secretion remains 
controversial (Gentilcore et al; 2005). The reason why 
fructose and galactose did not induce increase in 
intestinal blood flow inspite of their similarities to 
Nitric oxide and intestinal glucose uptake 
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glucose in structure is not clear. Perhaps, the difference 
in their vascular responses may be related to their 
isomerism. Further studies may throw more light on 
this.  
 
Determination of intestinal glucose uptake was based 
on indirect Fick’s law which is calculated as the 
product of Intestinal Blood Flow (IBF) and Arterio-
Venous glucose difference ((A – V) glucose). In other 
words, the intestinal glucose uptake was determined by 
both the blood flow and arterio-venous glucose 
difference. Thus, in the present study, glucose infusion 
significantly increased both the intestinal blood flow 
and (A – V) glucose, thereby causing a significant rise 
in intestinal glucose uptake. The observed abolition of 
the glucose –induced hyperemia in the jejunum by the 
NOS inhibitor, L-NAME suggests the involvement of 
nitric oxide in glucose-induced hyperaemia in the 
canine jejunum. This result agrees with previous 
reports which showed that nitric oxide mechanisms are 
important in splanchnic blood flow.  In pigs, L-NAME 
attenuates the increase in mesenteric blood flow after 
meal (Alemany et al; 1997) and in rats, intestinal 
arteriolar distension induced by topical application of 
glucose is blocked by L-NAME (Matheson et al; 1997).  
Since fructose and galactose had no effect on intestinal 
blood flow, it is reasonable to conclude that the effect 
of the two sugars on intestinal glucose uptake is 
essentially due to their effects on glucose extraction by 
the gut. Again, since L-NAME had no effect on 
intestinal glucose extraction, it is not unreasonable to 
conclude that nitric oxide is not involved in increasing 
intestinal glucose uptake induced by infusion of 
fructose or galactose.  
 
In conclusion, these results show that nitric oxide may 
have played a vasodilatory role in increasing blood 
flow which contributed significantly to increase 
intestinal glucose uptake induced by glucose. However, 
nitric oxide did not play any role in the increased 
intestinal glucose uptake following administration of 
fructose and galactose. These results show that the 
increased intestinal glucose uptake induced by glucose 
is mediated, at least in part, by nitric oxide- dependent 
vasodilation which increases blood flow; however, 
fructose or galactose-induced increase in intestinal 
glucose uptake is nitric oxide- independent. 
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